Viking Therapeutics Inc. | Mutual Funds
Mutual Funds that own Viking Therapeutics Inc.
Vanguard Total Stock Market Index Fund
1,170,181
1.93%
0
0%
07/31/2018
Janus Global Life Sciences Fund
951,301
1.57%
951,301
0.31%
06/30/2018
iShares Russell 2000 ETF
911,423
1.5%
-486
0.03%
09/06/2018
Meridian Small Cap Growth Fund
869,254
1.43%
869,254
0.69%
03/31/2018
Vanguard Extended Market Index Fund
600,744
0.99%
4,349
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
414,230
0.68%
0
0.05%
09/06/2018
Vanguard Explorer Fund
263,227
0.43%
263,227
0.02%
06/30/2018
Dreyfus Select Managers Small Cap Growth Fund
252,206
0.42%
42,646
0.36%
07/31/2018
Fidelity Spartan Extended Market Index Fund
204,683
0.34%
0
0.01%
07/31/2018
DWS Biotech
132,143
0.22%
132,143
0.36%
06/29/2018
| Address |
12340 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.vikingtherapeutics.com |
| Updated |
07/08/2019 |
| Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. |
